BiotechTube
Home/Invirsa/Rachael Wingo, MBA
RW

Rachael Wingo, MBA

CFO

Invirsa

Therapeutic Areas

OphthalmologyRespiratoryMedical Countermeasures

Invirsa Pipeline

DrugIndicationPhase
INV-102Ocular Injury from Sulfur Mustard GasPre-clinical/Phase 2

Leadership Team at Invirsa

RS
Robert Shalwitz, M.D.
CEO
IS
Isaiah Shalwitz
Program Manager/Biostatistician
View full Invirsa profile